/PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of...
/PRNewswire/ -- Electromedical Technologies, Inc. (OTC-QB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of...
/PRNewswire/ -- Electromedical Technologies, Inc. (OTC-QB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of...
/PRNewswire/ -- Electromedical Technologies, Inc. (OTC-QB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of...
Electromedical Technologies, Inc. (OTCQB: EMED) is engaged as a commercial-stage bioelectronic medical device company, which is focused on developing treatments
/PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of...
SCOTTSDALE, Ariz., Aug. 18, 2022 Electromedical Technologies, Inc. (OTCQB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and...
/PRNewswire/ -- InvestorsHub NewsWire -- Electromedical Technologies, Inc. (OTC: EMED) (the "Company"), a pioneer in the development and manufacturing of...
/PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of advanced...
•The Stage I research program now includes development of targeted Alzheimer's Disease therapy using bioelectronics •Experienced neuroscientist Dr. Sholpan Askarova to lead neuromodulation research...